Jiangsu Flag Chemical Industry Co., Ltd. (SHE:300575)

Orchard Therapeutics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	377.72	466.89	427.77	481.61	402.27	685.68
Trading Asset Securities	29.75	29.75	42.28	46.09	46.76	92.75
Cash & Short-Term Investments	407.47	496.63	470.05	527.7	449.03	778.43
Cash Growth	-12.79%	5.66%	-10.93%	17.52%	-42.32%	56.71%
Accounts Receivable	710.94	677.56	348.94	600.95	457.28	265.4
Other Receivables	0.64	0.8	1.2	12.22	0.76	8.69
Receivables	711.58	678.36	350.14	613.17	458.04	274.1
Inventory	628.33	522.29	429.61	484.07	360.56	186.41
Other Current Assets	112.06	109.4	102.69	177.17	169.54	115.09
Total Current Assets	1,859	1,807	1,352	1,802	1,437	1,354
Property, Plant & Equipment	2,342	2,369	2,284	1,983	1,475	1,057
Long-Term Investments	12	12.13	-	74.36	47.45	1.24
Goodwill	29.88	29.88	29.88	28.61	-	-
Other Intangible Assets	147.48	146.99	150.93	109.63	91.69	93.95
Long-Term Deferred Tax Assets	38.13	31.34	15.56	19.32	11.2	7.97
Long-Term Deferred Charges	10.61	11.14	15.88	10.1	13.09	15.86
Other Long-Term Assets	14.5	5.02	7.51	13.38	78.69	9.85
Total Assets	4,454	4,412	3,856	4,040	3,155	2,540
Accounts Payable	705.55	632.38	454.34	878.94	666.7	354.65
Accrued Expenses	28.93	58.21	55.7	68.27	53.84	48.89
Short-Term Debt	568.64	569.88	326.04	143.3	218.37	217.42
Current Portion of Long-Term Debt	82.08	111.32	143.01	37.02	19.5	48.39
Current Income Taxes Payable	10	3.39	2.97	23.99	14.25	0.51
Current Unearned Revenue	28.57	30.64	11.13	6.21	34.81	35.25
Other Current Liabilities	148.01	139.88	51.46	81.42	61.55	87.49
Total Current Liabilities	1,572	1,546	1,045	1,239	1,069	792.6
Long-Term Debt	645.97	597.1	497.03	705.13	394.7	271.66
Long-Term Unearned Revenue	42.48	43.76	45.3	33.4	25.3	12.57
Long-Term Deferred Tax Liabilities	1.86	1.95	2.29	6.02	2.74	3.61
Total Liabilities	2,262	2,189	1,589	1,984	1,492	1,080
Common Stock	464.76	464.76	464.76	310.06	207.02	138.05
Additional Paid-In Capital	198.8	198.8	198.8	357.16	453.61	506.16
Retained Earnings	1,420	1,454	1,498	1,409	1,051	892.63
Treasury Stock	-	-	-	-29.97	-55.18	-79.34
Comprehensive Income & Other	6.57	4.25	2.77	-	-	-
Total Common Equity	2,090	2,122	2,165	2,046	1,656	1,458
Minority Interest	101.48	101.56	102.44	10.22	6.46	2.27
Shareholders' Equity	2,192	2,224	2,267	2,057	1,663	1,460
Total Liabilities & Equity	4,454	4,412	3,856	4,040	3,155	2,540
Total Debt	1,297	1,278	966.08	885.45	632.57	537.47
Net Cash (Debt)	-889.22	-781.66	-496.04	-357.75	-183.54	240.96
Net Cash Growth	-	-	-	-	-	939.54%
Net Cash Per Share	-2.29	-2.00	-1.06	-0.77	-0.40	0.52
Filing Date Shares Outstanding	464.76	464.76	464.76	465.09	465.79	465.92
Total Common Shares Outstanding	464.76	464.76	464.76	465.09	465.79	465.92
Working Capital	287.67	261	307.82	562.98	368.14	561.44
Book Value Per Share	4.50	4.57	4.66	4.40	3.56	3.13
Tangible Book Value	1,913	1,945	1,984	1,908	1,565	1,364
Tangible Book Value Per Share	4.12	4.19	4.27	4.10	3.36	2.93
Buildings	-	927.66	846	668.36	410.92	391.14
Machinery	-	2,175	1,811	1,431	1,033	836.82
Construction In Progress	-	260.67	395.98	524.99	517.7	214.99

Source: S&P Global Market Intelligence. Standard template. Financial Sources.